Stockscreener 앱 받기
2.65
14.72%
0.34
시간 외 거래:
2.65
전일 마감가:
$2.31
열려 있는:
$2.31
하루 거래량:
129.99K
Relative Volume:
1.86
시가총액:
$5.55M
수익:
$507.90K
순이익/손실:
$-32.18M
주가수익비율:
-0.1209
EPS:
-21.9125
순현금흐름:
$-31.81M
1주 성능:
+0.76%
1개월 성능:
-62.11%
6개월 성능:
-64.22%
1년 성능:
-87.42%
1일 변동 폭
$2.26
$2.705
1주일 범위
$2.1759
$2.98
52주 변동 폭
$2.1759
$3.8563
Co Diagnostics Inc Stock (CODX) Company Profile
명칭
Co Diagnostics Inc
전화
(801) 278-9769
주소
4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY
Compare CODX vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CODX
Co Diagnostics Inc
|
2.65 | 4.84M | 507.90K | -32.18M | -31.81M | -21.91 |
|
ABT
Abbott Laboratories
|
107.19 | 188.52B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.76 | 132.34B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.87 | 111.97B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.89 | 105.77B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.46 | 47.98B | 6.07B | 1.06B | 1.34B | 1.8063 |
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-08-12 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2021-12-29 | 개시 | Sidoti | Buy |
| 2021-03-29 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2020-05-20 | 업그레이드 | Maxim Group | Hold → Buy |
| 2020-05-18 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-09 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-03 | 다운그레이드 | Maxim Group | Buy → Hold |
모두보기
Co Diagnostics Inc 주식(CODX)의 최신 뉴스
HC Wainwright & Co. Reiterates Co-Diagnostics (CODX) Neutral Recommendation - MSN
Will Co Diagnostics Inc benefit from rising consumer demand2026 Sector Review & Weekly High Return Opportunities - baoquankhu1.vn
FOMO Trade: What analysts say about Co Diagnostics Inc stockMarket Risk Analysis & High Accuracy Trade Alerts - baoquankhu1.vn
Co-Diagnostics Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Webcast - The Herald Journal
Co-Diagnostics sets Mar. 31 webcast to review 2025 results - Stock Titan
Co-Diagnostics receives Japanese patent for PCR platform By Investing.com - Investing.com Nigeria
Utah's Co-Diagnostics joins Seoul global healthcare conference - Stock Titan
CODX Technical Analysis & ETF Price Forecast - Intellectia AI
Co-Diagnostics receives Japanese patent for PCR platform - Investing.com South Africa
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Co-Diagnostics, Inc.(NasdaqCM: CODX) added to NASDAQ Composite Index - marketscreener.com
Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform Technologies - Barchart
Co-Diagnostics Surges After Market Expansion News - timothysykes.com
Co-Diagnostics regains Nasdaq listing compliance By Investing.com - Investing.com South Africa
Co-Diagnostics Regains Nasdaq Compliance and Listing Status - TipRanks
Co-Diagnostics Regains Compliance with Nasdaq Listing Requirements - The Herald Journal
Co-Diagnostics (NASDAQ: CODX) cleared to resume trading on Nasdaq - Stock Titan
Co-Diagnostics regains Nasdaq listing compliance - Investing.com
Maxim Group downgrades Co-Diagnostics (CODX) - MSN
Fundamentals Check: Will Co Diagnostics Inc benefit from rising consumer demandJuly 2025 Gainers & Daily Momentum Trading Reports - baoquankhu1.vn
CODX Stock Jumped A Whopping 148% Today: What’s Driving The Super Rally? - Stocktwits
CODXCo-Diagnostics Inc Latest Stock News & Market Updates - Stock Titan
Establishment Labs and Co-Diagnostics: A Comparison of Medical Companies - National Today
CODX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Inside Dubai's World Health Expo, Co-Diagnostics meets MENA lab leaders - Stock Titan
India grants license for CoSara PCR device; TB, HPV tests pending - Stock Titan
India JV wins ISO seal to build cheaper Co-Dx home PCR devices - Stock Titan
Co-Diagnostics (CODX) Downgraded to Hold by Maxim Group Today | CODX Stock News - GuruFocus
Co-Diagnostics Shares Transition to Over-the-Counter Trading - AD HOC NEWS
Co-Diagnostics Faces Nasdaq Delisting After Bid Price Noncompliance - The Globe and Mail
CODX Stock Price, Forecast & Analysis | CO-DIAGNOSTICS INC (NASDAQ:CODX) - Chartmill
Co-Diagnostics (CODX) Price Target Increased by 2,900.00% to 38.25 - Nasdaq
Co-Diagnostics to be delisted from Nasdaq, trading to move to OTC Market By Investing.com - Investing.com India
Co-Diagnostics to be delisted from Nasdaq, trading to move to OTC Market - Investing.com Nigeria
Co-Diagnostics Received Notice of Delisting - TradingView — Track All Markets
Co-Diagnostics, Inc.(OTCPK: CODX) dropped from NASDAQ Composite Index - marketscreener.com
Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships - StreetInsider
Why Co Diagnostics Inc. stock could be next big winnerShare Buyback & Stepwise Trade Execution Plans - Улправда
CODX stock plunges to all-time lows on 1-for-30 reverse stock split approval - MSN
Co-Diagnostics, Inc. to Host Booth at the 2024 UHCA/UCAL Fall Convention and Expo on Oct 2-3 - marketscreener.com
CODX Shares Dip Despite Australian Patent Grant for Co-Dx PCR Platform - Finviz
Co-Diagnostics Approves Reverse Stock Split to Maintain Listing - The Globe and Mail
Co-Diagnostics announces 1-for-30 reverse stock split - Yahoo Finance
Institution Moves: Is Co Diagnostics Inc stock a buy in volatile marketsDip Buying & Daily Volume Surge Trade Alerts - moha.gov.vn
Co-Diagnostics (CODX) Announces 1-for-30 Reverse Stock Split - GuruFocus
Co-Diagnostics to Effect a 1-for-30 Reverse Stock Split - MarketScreener
CODX Stock Plunges To All-Time Lows On 1-for-30 Reverse Stock Split Approval - Stocktwits
Co-Diagnostics stock plunges after announcing 1-for-30 reverse split By Investing.com - Investing.com South Africa
Co-Diagnostics announces 1-for-30 reverse stock split By Investing.com - Investing.com Nigeria
Co-Diagnostics stock plunges after announcing 1-for-30 reverse split - Investing.com Canada
Co Diagnostics Inc (CODX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.85%
1.86%
자본화:
|
볼륨(24시간):